tm logo
Trademark Search
EVAMPLIX (BALSTILIMAB)

View On IC.GC.CA

EVAMPLIX (BALSTILIMAB)
WITHDRAWN

on 31 Dec 1969

Last Applicant/ Owned by

AGENUS INC.

3 Forbes RoadLexington MA 02421

US

Serial Number

2170281 filed on 19th Jan 2022

Correspondent Address

P.O. Box 2088, Station DOttawa

ONTARIO

CA

K1P5W3

EVAMPLIX (BALSTILIMAB)

Vienna Information

26 . 15 . 9

CubesCubes

Trademark usage description

pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections Read More

Classification Information

Class [005]
Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; biological preparations, namely, antibodies for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases.

Classification kind code

11

Mark Details

Serial Number

2170281

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 13th Jun 2023		Search Recorded
Submitted for opposition 20
on 13th Jun 2023		Examiner's First Report
Submitted for opposition 223
on 13th Jun 2023		Total Provisional Refusal
Submitted for opposition 256
on 03rd Jan 2023		Notification of Possible Opposition Sent
Submitted for opposition 48
on 11th Mar 2022		Agent Changed
Submitted for opposition 257
on 03rd Mar 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 02th Mar 2022		Formalized
Submitted for opposition 1
on 02th Mar 2022		Created
Submitted for opposition 228
on 19th Jan 2022		International Registration
Submitted for opposition 30
on 19th Jan 2022		Filed